|
| Status |
Public on Apr 17, 2018 |
| Title |
BRD4 profiling identifies critical Chronic Lymphocytic Leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
29386193 |
| |
| Submission date |
Jan 24, 2018 |
| Last update date |
Mar 26, 2019 |
| Contact name |
Hatice Gulcin Ozer |
| E-mail(s) |
[email protected]
|
| Phone |
614-366-1538
|
| Organization name |
The Ohio State University
|
| Department |
Biomedical Informatics
|
| Street address |
1800 Cannon Dr
|
| City |
Columbus |
| State/province |
OH |
| ZIP/Postal code |
43210 |
| Country |
USA |
| |
|
| Platforms (3) |
| GPL17586 |
[HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version] |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
| GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
| Samples (58)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE109411 |
BRD4 profiling identifies critical Chronic Lymphocytic Leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor [ChIP-seq] |
| GSE109587 |
BRD4 profiling identifies critical Chronic Lymphocytic Leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor [expression profiling] |
|
| Relations |
| BioProject |
PRJNA431438 |
Less...
More...